DSM and Firmenich have merged, establishing a new company that brings together one of the largest innovation and creation communities in nutrition, health, and beauty. With a nearly 30,000 strong team and unparalleled capabilities built on more than a century of cutting-edge science, dsm-firmenich will be a trailblazer in the reinvention, manufacturing, and combination of vital nutrients, flavors, and fragrances.

More information, including all the documents associated with this merger are available at www.dsm-firmenich.com.

4 May 2023

DSM-Firmenich AG announced an evolution in the company’s CEO structure ahead of the completion of its merger of equals between DSM and Firmenich.

The press release can be accessed here. 

17 Apr 2023

DSM and Firmenich jointly announce that the Exchange Offer to DSM shareholders is unconditional and all transaction conditions have been satisfied or waived. As a result, trading in dsm-firmenich shares on Euronext Amsterdam will commence on 18 April 2023 ahead of the contribution of the Firmenich business on 8 May 2023.

DSM shareholders who have not yet tendered their DSM shares have the opportunity to do so under the same terms and conditions as applicable to the exchange offer until 28 April 2023 at 17:40 hours CEST.

The press release can be found on the transaction website here. 

4 Apr 2023

DSM and Firmenich confirm that they have obtained competition clearance from the Competition Commission of India (CCI) and now have competition clearance in all required jurisdictions. DSM shareholders have until 17:40 CEST on 17 April 2023 to tender their shares.

The press release and more information about the exchange offer to DSM shareholders can be accessed here. 

23 Feb 2023 

DSM and Firmenich jointly announce that they have obtained the unconditional competition clearance from the European Commission on 22 February 2023. This follows the unconditional competition clearance of China’s State Administration for Market Regulation (SAMR) received on 16 February 2023. Consequently, competition clearance has been obtained in nine out of the ten jurisdictions required to satisfy the offer condition relating to competition clearances.

The press release can be accessed here. 

23 Jan 2023 

DSM and Firmenich confirm that the acceptance period during which DSM shareholders can tender their shares as part of the Exchange Offer that launched on 22 November 2022, has been extended. The reason for this extension is that not all competition clearances will be obtained by 31 January 2023 although, to date, no substantive competition concerns have been identified.

13 Jun 2022 

DSM and Firmenich hosted a joint Capital Markets Day for institutional investors and equity analysts, to provide a deeper understanding of Firmenich’s businesses and to present DSM-Firmenich AG, outlining its key value drivers, demonstrating how the complementary nature of the companies can enable enhanced innovation and co-creation with their customers, and through this, increase returns and deliver long-term sustainable growth and shareholder value.

Held at the Palais Brongniart, the historical Paris stock exchange, the recording of the presentations and the Q&A session is available to be watched back here.

31 May 2022 

DSM and Firmenich announced an intention to merge to become the leading creation and innovation partner in nutrition, beauty and well-being. The combination will bring together Firmenich’s unique leading Perfumery and Taste businesses, its world-class science platforms and associated co-creation capabilities with DSM’s outstanding Health and Nutrition portfolio and renowned scientific expertise.

The press release can be accessed here.